PRGO — PERRIGO Co plc

—
NYSE · Health Care · Pharmaceuticals · CIK 1585364 ·
Last close
$15.76
Market Cap
$2.19B
52W High
$17.02
52W Low
$8.81
ADV30
2,364,412
Next earnings
2026-11-04

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 988,600,000 320,800,000 27,200,000 -27,500,000 7,484,900,000 436,600,000 5,044,500,000
Jun 2026 1,022,800,000 313,900,000 39,000,000 74,500,000 7,609,500,000 399,700,000 5,093,700,000
Mar 2026 969,200,000 325,500,000 33,600,000 -398,600,000 7,983,300,000 357,200,000 5,484,500,000
Dec 2025 1,109,600,000 362,200,000 84,400,000 -1,418,100,000 8,535,200,000 531,600,000 5,599,700,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$240,500,000
Investing CF
$298,900,000
Financing CF
$-532,200,000
CapEx
$-72,400,000
Dividends Paid
$-160,200,000
Buybacks
—
EPS Diluted TTM
$-12.76
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-4,029,300,000
Inventory
$1,013,800,000
Receivables
$685,500,000
ST Investments
—
EBIT TTM
$-1,485,100,000
Pretax Income TTM
$-1,652,900,000
Interest Exp TTM
$163,100,000
Analysts
3

Yahoo Snapshot (yfinance, live)

Total Revenue
$4,090,200,064
EBITDA
$560,000,000
Free Cash Flow
$723,449,984
Enterprise Value
$5,227,409,920
Total Cash
$436,600,000
Total Debt
$3,464,000,000
Shares Out
138,801,872
Trailing EPS
$-12.47
Book Value
$17.58
ROE
-50.2%
ROA
1.6%
Div Yield
7.32%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 4,253,100,000 312,800,000 -1,425,400,000 8,535,200,000 5,599,700,000 2,935,500,000 238,500,000
Dec 2024 4,373,400,000 311,900,000 -171,800,000 9,647,700,000 5,328,300,000 4,319,400,000 362,900,000
Dec 2023 4,655,600,000 284,100,000 -12,700,000 10,809,100,000 6,041,200,000 4,767,900,000 405,500,000
Dec 2022 4,451,600,000 121,400,000 -140,600,000 11,017,300,000 6,175,200,000 4,842,100,000 307,300,000

TTM Snapshot

Revenues TTM
$4,144,900,000
NetIncome TTM
$-1,734,700,000
OpCashFlow TTM
—
Assets (Latest)
$7,609,500,000
Forward EPS
$2.30

Max Pain — expiry 2027-01-15

max pain strike: $12.50 · spot: $16.94 · call oi: 3,366 · put oi: 1,247
Expected Move to 2027-01-15: ±$3.12 (18.45%) — implied range $13.82 – $20.07 · ATM straddle on $17.50 strike

Peers — same industry

TickerNameMarket CapLastDaily %
GRFS Grifols SA $2.23B $8.63 —
LKFT Lakefront Biotherapeutics NV $2.25B $34.39 —
PHVS Pharvaris N.V. $2.27B $32.28 —
PVLA PALVELLA THERAPEUTICS, INC. $2.11B $144.35 —
PBH Prestige Consumer Healthcare Inc. $2.29B $48.22 —

News headlines (Yahoo Finance, 1h cache)

Perrigo to Attend the Jefferies Miami Consumer Conference
2026-11-11 13:30 · Yahoo
Perrigo (PRGO) Stock Could Trade Below Fair Value Following A 54% Five Year Fall
2026-11-07 15:19 · Yahoo
How Investors May Respond To Perrigo (PRGO) Weak 2026 Outlook
2026-11-07 12:16 · Yahoo
Is Perrigo (PRGO) Undervalued After Its 2026 Sales Guidance Cut?
2026-11-07 05:17 · Yahoo
Perrigo: 3 Key Takeaways for Long-Term Investors
2026-11-07 02:31 · Yahoo
Perrigo Co PLC (PRGO) (Q3 2026) Earnings Call Highlights: Margin Gains and Share Growth Offset ...
2026-11-05 01:10 · Yahoo
Perrigo (PRGO) Q3 2026 Earnings Call Transcript
2026-11-04 19:01 · Yahoo
Perrigo Company plc Q3 2026 Earnings Call Summary
2026-11-04 18:53 · Yahoo
Perrigo (PRGO) Reports Q3 Earnings: What Key Metrics Have to Say
2026-11-04 13:30 · Yahoo
Perrigo (PRGO) Surpasses Q3 Earnings Estimates
2026-11-04 11:50 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.